Francisco Marı́n

Research interests

Publications

• Polypill Strategy in Secondary Cardiovascular Prevention

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2208275

• 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

  EP Europace · 2018 · 10.1093/europace/euy174

• 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascu

  EP Europace · 2018 · https://doi.org/10.1093/europace/euy174

• 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascu

  EP Europace · 2018 · https://doi.org/10.1093/europace/euy174

• Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

  EP Europace · 2017 · https://doi.org/10.1093/europace/eux301

• Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

  EP Europace · 2017 · https://doi.org/10.1093/europace/eux091

• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)

  EP Europace · 2017 · https://doi.org/10.1093/europace/eux177

• Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

  EP Europace · 2017 · https://doi.org/10.1093/europace/eux163

• Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

  EP Europace · 2017 · https://doi.org/10.1093/europace/eux301

• Teriparatide for osteoporosis: importance of the full course

  Osteoporosis International · 2016 · 10.1007/s00198-016-3534-6

• Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome

  Critical Reviews in Food Science and Nutrition · 2016 · https://doi.org/10.1080/10408398.2015.1126549

• Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

  American Heart Journal · 2016 · 10.1016/j.ahj.2016.05.007

• Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

  EP Europace · 2015 · https://doi.org/10.1093/europace/euv202

• Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)

  EP Europace · 2015 · https://doi.org/10.1093/europace/euv190

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Hea

  European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu298

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Asso

  European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu298

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Asso

  European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu298

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

  European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu298

• The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.08.1623

• Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

  Thrombosis and Haemostasis · 2013 · 10.1160/th13-07-0556

• Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

  CHEST Journal · 2012 · 10.1378/chest.12-0608

• Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

  EP Europace · 2011 · https://doi.org/10.1093/europace/eur126

• Bleeding risk assessment and management in atrial fibrillation patients

  Thrombosis and Haemostasis · 2011 · https://doi.org/10.1160/th11-10-0690

• Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary—a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

  European Heart Journal · 2010 · https://doi.org/10.1093/eurheartj/ehq117

• Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

  Thrombosis and Haemostasis · 2009 · https://doi.org/10.1160/th09-08-0580

• Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation

  Journal of the American College of Cardiology · 2008 · https://doi.org/10.1016/j.jacc.2007.11.035

• Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

  Journal of the American College of Cardiology · 2007 · https://doi.org/10.1016/j.jacc.2007.06.062

• Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass Grafting

  The American Journal of Cardiology · 2005 · https://doi.org/10.1016/j.amjcard.2005.07.124

• Soluble E-selectin in cardiovascular disease and its risk factors

  Thrombosis and Haemostasis · 2003 · 10.1160/th02-09-0083

Current projects

No projects listed.